FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Contract Pharmacal Major Extra Strength Acetaminophen Tablets Recall

Major Extra Strength Acetaminophen Tablets, 500 mg Pain Reliever/Fever Reducer, package…

Contract Pharmacal Corporation · Hauppauge, NY

Risk level
Class II
Reported by FDA
Feb 19, 2020
Recall ID
D-0858-2020
Check your lot numberHow we source this data

Summary

Contract Pharmacal recalled Major Extra Strength Acetaminophen Tablets starting Feb 3, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0858-2020 on Feb 19, 2020. Reason: Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle. Status: Terminated.

Why it was recalled

Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle.

Product description

Major Extra Strength Acetaminophen Tablets, 500 mg Pain Reliever/Fever Reducer, packaged in a) 100-count bottles (NDC 0904-6730-60; UPC 3 09046 73060 6) and b) 1000-count bottles (NDC 0904-6730-80; UPC 3 09046 73080 4) Distributed by Major Pharmaceuticals 17177 N. Laurel Park Drive, Suite 233 Livonia, MI 45162 USA

Lot numbers, UPCs & expiration codes

Lot #: 193005, Exp. Date 08/21

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0858-2020
Classification
Class II
Status
Terminated
Recall initiated
Feb 3, 2020
FDA report date
Feb 19, 2020
Quantity
a) 1176 bottles b) 6,216 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Contract Pharmacal Corporation

Original FDA data

Every field from FDA enforcement report D-0858-2020, exactly as published.

Show all FDA fields
City
Hauppauge
State
NY
Status
Terminated
Country
United States
Event ID
84857
Address
135 Adams Ave
Code information
Lot #: 193005, Exp. Date 08/21
Postal code
11788-3633
Report date
Feb 19, 2020
Product type
Drugs
Recall number
D-0858-2020
Classification
Class II
Recalling firm
Contract Pharmacal Corporation
Product quantity
a) 1176 bottles b) 6,216 bottles
Termination date
Apr 22, 2024
Reason for recall
Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Major Extra Strength Acetaminophen Tablets, 500 mg Pain Reliever/Fever Reducer, packaged in a) 100-count bottles (NDC 0904-6730-60; UPC 3 09046 73060 6) and b) 1000-count bottles (NDC 0904-6730-80; UPC 3 09046 73080 4) Distributed by Major Pharmaceuticals 17177 N. Laurel Park Drive, Suite 233 Livonia, MI 45162 USA
Distribution pattern
Nationwide within the United States
Recall initiation date
Feb 3, 2020
Initial firm notification
Letter
Center classification date
Feb 27, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0858-2020, published Feb 19, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls